NSEUpdates2d ago · 28 Aug 2026, 02:41 pm
Updates
Solara Active Pharma Sciences Limited · SOLARA
✦ AI SummaryRegulatory
Solara Active Pharma Sciences Limited has received a Rectification Order from the Assistant Commissioner of Income Tax, Central Circle 3, Thane, rectifying the error in tax computation and dropping the tax demand of Rs. 161.92 Crores raised pursuant to the Demand Notice received on March 17, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
SOLARA: Solara Active Pharma Sciences Limited has informed the Exchange regarding Intimation in connection with the receipt of Rectification Order.
Attachments (1)
📄pdf
Download →
SOLARA_28082026144034_SE_Intimation___rectified_order.pdf
View document text
Corporate Office:
Solara Active Pharma Sciences Limited
TICEL Bio Park, 6th Floor,
Module No. 601, 602, 603, Phase II – CSIR Road,
Taramani, Chennai, Tamil Nadu – 600113.
Tel: +91 44 4344 6700
Fax: +91 44 47406190
E-mail: investors@solara.co.in
Website: www.solara.co.in
Date: August 28, 2026
The BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla Complex,
Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1
Dear Sir / Madam,
Subject: Intimation in connection with the receipt of Rectification Order
This is with reference to the intimation filed by the Company on March 18, 2026, disclosing the details of a
Demand notice received from Deputy Commissioner of Income Tax, Income Tax Department.
The Company had filed an application for rectification of the Demand under Section 154 of the Income Tax
Act, 1961, on the grounds that the tax demand had been computed incorrectly by the Income Tax Department
and required correction. Pursuant to the said application, the Company has received a Rectification Order under
Section 154 read with Section 147 of the Income Tax Act, 1961, from the Assistant Commissioner of Income
Tax, Central Circle 3, Thane. The order rectifies the error in the tax computation and consequently drops the
Tax demand.
The details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
are enclosed as Annexure A.
The above information will also be available on the website of the Company i.e. https://solara.co.in/
This is for your information and records.
Thanking You,
Yours Faithfully,
For Solara Active Pharma Sciences Limited
Pooja Jaya Kumar
Company Secretary and Compliance Officer
ICSI Membership No: A57415
Encl. as above
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636
Registered Office: Cyber One, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033
Corporate Office:
Solara Active Pharma Sciences Limited
TICEL Bio Park, 6th Floor,
Module No. 601, 602, 603, Phase II – CSIR Road,
Taramani, Chennai, Tamil Nadu – 600113.
Tel: +91 44 4344 6700
Fax: +91 44 47406190
E-mail: investors@solara.co.in
Website: www.solara.co.in
Annexure A
Details as required under SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
Sr. No Particulars Details
1. Name of the listed company Solara Active Pharma Sciences Limited
2. Type of communication received The Company has received a Rectification Order
under Section 154 read with Section 147 of the
Income-tax Act, 1961.
3. Date of receipt of communication Company received the Rectification Order on August
08, 2026
4. Authority from whom communication Assistant Commissioner of Income Tax, Central
received Circle-3, Thane
5. Brief summary of the material contents of The Company had filed an application for rectification
the communication received, including under Section 154 of the Income-tax Act, 1961, as the
reasons for receipt of the communication tax demand of Rs. 161.92 Crores raised pursuant to the
Demand Notice received on March 17, 2026, was
incorrectly computed. Upon examination of the
rectification application, the Assistant Commissioner
of Income Tax, Central Circle 3, Thane, passed a
Rectification Order under Section 154 read with
Section 147 of the Income-tax Act, 1961, rectifying
the error and reducing the tax demand to Nil.
6. Period for which communication would be Assessment Year 2019-20
applicable, if stated
7. Expected financial implications on the On passing of Rectification Order, there is no pending
listed company, if any demand on the Company against the Demand Notice
received on March 17, 2026. There is no impact on
Financials /operation or other activities of the
Company in this regard as the demand has been
dropped.
8. Details of any aberrations/non-compliances The rectification order does not identify any
identified by the authority in the aberration, non-compliance, violation, or default on
communication the part of the Company.
9. Details of any penalty or restriction or Nil
sanction imposed pursuant to the
communication
10. Action(s) taken by listed company with No further action is required to be taken by the
respect to the communication Company in relation to the said demand.
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636
Registered Office: Cyber One, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033